Department of Orthopaedic Surgery, Programs for Applied Biomedicine, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima, Japan.
J Cell Mol Med. 2010 Oct;14(10):2495-505. doi: 10.1111/j.1582-4934.2009.00898.x.
MicroRNA (miRNA)s are a class of non-coding RNAs that regulate gene expression post-transcriptionally. Muscle-specific miRNA, miRNA (miR)-1, miR-133 and miR-206 play a crucial role in the regulation of muscle development and homeostasis. Muscle injuries are a common musculoskeletal disorder, and the most effective treatment has not been established yet. The purpose of this study was to demonstrate that a local injection of double-stranded (ds) miR-1, miR-133 and 206 can accelerate muscle regeneration in a rat skeletal muscle injury model. After the laceration of the rat tibialis anterior muscle, ds miR-1, 133 and 206 mixture mediated atelocollagen was injected into the injured site. The control group was injected with control siRNA. At 1 week after injury, an injection of miRNAs could enhance muscle regeneration morphologically and physiologically, and prevent fibrosis effectively compared to the control siRNA. Administration of exogenous miR-1, 133 and 206 can induce expression of myogenic markers, MyoD1, myogenin and Pax7 in mRNA and expression in the protein level at 3 and 7 days after injury. The combination of miR-1, 133 and 206 can promote myotube differentiation, and the expression of MyoD1, myogenin and Pax7 were up-regulated in C2C12 cells in vitro. Local injection of miR-1, 133 and 206 could be a novel therapeutic strategy in the treatment of skeletal muscle injury.
微小 RNA(miRNA)是一类非编码 RNA,在后转录水平调节基因表达。肌肉特异性 miRNA,miR-1、miR-133 和 miR-206 在调节肌肉发育和稳态中起着至关重要的作用。肌肉损伤是一种常见的肌肉骨骼疾病,目前尚未确立最有效的治疗方法。本研究旨在证明,双链(ds)miR-1、miR-133 和 206 的局部注射可以加速大鼠骨骼肌损伤模型中的肌肉再生。在大鼠胫骨前肌切开后,将 ds miR-1、133 和 206 混合物介导的去端胶原注入损伤部位。对照组注射对照 siRNA。损伤后 1 周,与对照 siRNA 相比,miRNA 的注射在形态和生理上均可增强肌肉再生,并有效预防纤维化。外源性 miR-1、133 和 206 的给药可在损伤后 3 天和 7 天在 mRNA 和蛋白水平上诱导肌生成标志物 MyoD1、myogenin 和 Pax7 的表达。miR-1、133 和 206 的组合可促进肌管分化,并且体外 C2C12 细胞中 MyoD1、myogenin 和 Pax7 的表达上调。miR-1、133 和 206 的局部注射可能是骨骼肌损伤治疗的一种新的治疗策略。